USES OF EGFR/HER2 INHIBITOR COMBINED WITH PYRIMIDINE-TYPE ANTI-METABOLIC DRUG

• 收藏
• 分享

专利权人:

Jiangsu Hengrui Medicine Co.; Ltd.

发明人:

Jianjun ZOU,Guoqing CAO,Xiaoyu ZHU

申请号：

US16478010

公开号：

US20190358212A1

申请日:

2018.01.19

申请国别(地区):

US

年份:

2019

代理人:

摘要：

Uses of an EGFR/HER2 inhibitor combined with a pyrimidine-type anti-metabolic drug are provided. Specifically, uses of an EGFR/HER2 receptor tyrosine kinase inhibitor combined with pyrimidine-type anti-metabolic drug in the preparation of drugs for treating cancers are provided.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/